Revvity Signals Launches ChemDraw® V21 Software, Empowering Researchers to Rapidly Create Chemically Intelligent Microsoft PowerPoint Reports

Press Release
March 1, 2022

WALTHAM, Mass. – March 1st, 2022 – Revvity Signals, a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw^® software featuring the ability to import, animate and share 3D chemical structures natively in the Microsoft® PowerPoint® application with one click.

The key enhancement, to a tool used by millions of scientists around the world, helps chemists create more intelligent research reports quickly and easily — improving information sharing and collaboration and supporting real-time decision making.

Using the new ChemDraw V21 software, chemists simply paste a live 3D rendering of their molecule, with its atom and bond color highlights fully retained, natively into the Microsoft PowerPoint application where they can view, rotate and share the image. Researchers can also save molecules as 3D printable objects. No other chemical drawing application in the industry today provides these intuitive capabilities which eliminate the need to use specialized software with steep learning curves.

Part of the Revvity Signals ChemOffice^®+ Cloud platform, the software also continues to allow users to quickly perform chemical structure searches across disparate Microsoft documents and easily create reports of their chemistry experiments in Revvity Signal's Cloud-Native Signals Notebook™ electronic lab notebook (ELN).

“ChemDraw software and the ChemOffice+ Cloud platform are all about simplifying, facilitating, and accelerating chemistry communication to transform chemical drawings into shareable chemical knowledge,” said Kevin Willoe, VP and GM of Revvity Signals. “With this latest ChemDraw software release, chemists working on new drugs or materials can go from a 2D to 3D world in a snap and help drive more fluid collaboration and data-rich, timely decision making.”

ChemDraw software is part of Revvity Signal's extensive informatics portfolio which is used by more than 2 million scientists around the globe today. Pharmaceutical, agrochemical, advanced materials, and food industries rely on Revvity Signal's cloud-based, electronic notebooks and laboratory informatics solutions to capture, store and analyze research data, collaborate, and support data-driven R&D and clinical decisions.